Half-year 2025 results on track - Full Year 2025 targets confirmed - Atos
2 weeks ago • Google News
Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in .
2 weeks ago • Google News
2 weeks ago • Google News